KI-MS2-008
KI-MS2-008 is a selective Max binder. KI-MS2-008 results in the stabilization of Max homodimers and the attenuation of Myc. KI-MS2-008 has anticancer activity against Myc-dependent cancer[1].
Product Specifications
UNSPSC
12352005
Target
C-Myc
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
O=S(C1=CC=CC=C1)(CCN2CC(C=CC=C3)=C3[C@H]4[C@](N=C(O4)C5=CC=CC=C5)(C2=O)CC6=CC=CC=C6)=O
Molecular Formula
C32H28N2O4S
Molecular Weight
536.64
References & Citations
[1]Boyd SR, et al. Max-imizing the Attenuation of Myc Using Small Molecules. Trends Pharmacol Sci. 2019 Sep;40 (9) :608-612.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Fibroblast Activation Protein alpha/FAP Antibody (427819) [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
FAB3715W 0.1 mL
Mouse Monoclonal Fibroblast Activation Protein alpha/FAP Antibody (427819) [DyLight 650]
Ask
View Details 
GTR15252227 1 Vial
Lentiviral mouse Sirt1 shRNA (UAS) - Lentiviral mouse Sirt1 shRNA (UAS, RFP) (25)
Ask
View Details 